Novavax, Inc.

NVAX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$7.41+1.23%

2026-08-03

Financials

Valuation Metrics

Novavax, Inc.'s Market Cap is $1.22B. At end of 2025 it was $1.09B. Ranked #2390 of 3,112 in US market (top 77%), #962 of 1,445 on NASDAQ (top 67%), #179 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 67%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.22B	US#2,390/3,112 Sec#179/269
Revenue	$596M	US#2,260/3,112 Sec#73/269
Net Income	$-88M	US—/3,112 Sec—/269
Total Assets	$1.04B	US#2,427/3,112 Sec#95/269
Net Assets	$461M	US#2,311/3,112 Sec#119/269
Value
P/B	2.64x	US#1,529/3,112 Sec#77/269
P/S	2.04x	US#1,287/3,112 Sec#32/269
FCF Yield	-7.97%	US—/3,112 Sec—/269
Profitability
ROE	-19.04%	US#2,513/3,112 Sec#100/269
ROA	-8.42%	US#2,618/3,112 Sec#99/269
Op. Margin	-11.19%	US#2,644/3,112 Sec#101/269
Revenue Growth	-79.07%	US#2,917/3,112 Sec#173/269
Earnings Growth	-101.83%	US#2,075/3,112 Sec#66/269
Financial Health
Debt Ratio	257.50%	US#2,000/3,112 Sec#211/269
Total Debt	$295M	US#2,044/3,112 Sec#76/269
FCF	$-97M	US#2,584/3,112 Sec#150/269
Cash	$228M	US#1,623/3,112 Sec#103/269
Current Ratio	2.48x	US#997/3,112 Sec#210/269
Performance
1Y Return	12.96%	US#1,773/3,112 Sec#179/269
1M Return	-23.92%	US#3,004/3,112 Sec#242/269
From 52W High	-38.10%	US#2,472/3,112 Sec#193/269
1Y MDD	-35.94%	US#1,742/3,112 Sec#119/269
Trading
Volume	2,390,294 shares	US#766/3,112 Sec#68/269
Trading Value	$18M	US#2,038/3,112 Sec#155/269
Per Share
EPS	$2.72	US#1,050/3,112 Sec#32/269